These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19956958)

  • 1. Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.
    Joh EH; Lee IA; Han SJ; Chae S; Kim DH
    Int J Colorectal Dis; 2010 May; 25(5):545-51. PubMed ID: 19956958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.
    Lee JH; Lee B; Lee HS; Bae EA; Lee H; Ahn YT; Lim KS; Huh CS; Kim DH
    Int J Colorectal Dis; 2009 Feb; 24(2):231-7. PubMed ID: 19050899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
    Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
    Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
    Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
    J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
    Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
    Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
    Lee IA; Hyun YJ; Kim DH
    Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
    Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
    J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
    Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
    Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
    Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
    J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice.
    Lee IA; Bae EA; Lee JH; Lee H; Ahn YT; Huh CS; Kim DH
    Inflamm Res; 2010 May; 59(5):359-68. PubMed ID: 19882302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lancemaside A inhibits lipopolysaccharide-induced inflammation by targeting LPS/TLR4 complex.
    Joh EH; Kim DH
    J Cell Biochem; 2010 Nov; 111(4):865-71. PubMed ID: 20665542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
    Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
    Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
    Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
    Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
    Joh EH; Kim DH
    Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice.
    Lee IA; Kim EJ; Kim DH
    Planta Med; 2012 Jun; 78(9):896-8. PubMed ID: 22538477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
    Jang HM; Kang GD; Van Le TK; Lim SM; Jang DS; Kim DH
    Int Immunopharmacol; 2017 Apr; 45():90-97. PubMed ID: 28189973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
    Kang GD; Kim DH
    J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
    Lee IA; Park YJ; Yeo HK; Han MJ; Kim DH
    J Agric Food Chem; 2010 Oct; 58(20):10929-34. PubMed ID: 20923188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.
    Lee IA; Park YJ; Joh EH; Kim DH
    J Agric Food Chem; 2011 Dec; 59(24):13165-72. PubMed ID: 22060784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.